# Nicolet Bankshares Inc: financial statements, quarterly

NIC · NYSE · CIK 1174850 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nic.md) · [Financials](/companies/nic/financials.md) · [Filings](/companies/nic/filings.md) · [Insiders](/companies/nic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [38.4](/filings/0001174850-23-000038.md) | [39.3 d](/filings/0001174850-24-000010.md) | [41.2](/filings/0001174850-24-000025.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [14.7](/filings/0001174850-24-000046.md) | [6.8 d](/filings/0001174850-26-000077.md) | [6.5](/filings/0001174850-25-000023.md) | [7.5](/filings/0001174850-25-000036.md) | [8.3](/filings/0001174850-25-000062.md) | [8.7 d](/filings/0001174850-26-000077.md) | [7.6](/filings/0001174850-26-000110.md) | [8.7](/filings/0001174850-26-000164.md) | [10.1](/filings/0001174850-25-000062.md) | [9.9 d](/filings/0001174850-26-000077.md) | [3.8](/filings/0001174850-26-000110.md) | [15.6](/filings/0001174850-26-000164.md) |
| Net income | $m | [17.2](/filings/0001174850-24-000046.md) | [30.7 d](/filings/0001174850-26-000077.md) | [27.8](/filings/0001174850-25-000023.md) | [29.3](/filings/0001174850-25-000036.md) | [32.5](/filings/0001174850-25-000062.md) | [34.5 d](/filings/0001174850-26-000077.md) | [32.6](/filings/0001174850-26-000110.md) | [36.0](/filings/0001174850-26-000164.md) | [41.7](/filings/0001174850-25-000062.md) | [40.3 d](/filings/0001174850-26-000077.md) | [15.2](/filings/0001174850-26-000110.md) | [56.9](/filings/0001174850-26-000164.md) |
| Diluted EPS | $ per share | [1.14](/filings/0001174850-24-000046.md) | not reported | [1.82](/filings/0001174850-25-000023.md) | [1.92](/filings/0001174850-25-000036.md) | [2.10](/filings/0001174850-25-000062.md) | not reported | [2.08](/filings/0001174850-26-000110.md) | [2.34](/filings/0001174850-26-000164.md) | [2.73](/filings/0001174850-25-000062.md) | not reported | [0.81](/filings/0001174850-26-000110.md) | [2.62](/filings/0001174850-26-000164.md) |
| Basic EPS | $ per share | [1.16](/filings/0001174850-24-000046.md) | not reported | [1.86](/filings/0001174850-25-000023.md) | [1.96](/filings/0001174850-25-000036.md) | [2.16](/filings/0001174850-25-000062.md) | not reported | [2.14](/filings/0001174850-26-000110.md) | [2.40](/filings/0001174850-26-000164.md) | [2.81](/filings/0001174850-25-000062.md) | not reported | [0.83](/filings/0001174850-26-000110.md) | [2.68](/filings/0001174850-26-000164.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [8.4](/filings/0001174850-23-000038.md) | [8.5](/filings/0001174850-25-000008.md) | [8.4](/filings/0001174850-24-000025.md) | [8.6](/filings/0001174850-24-000036.md) | [8.6](/filings/0001174850-24-000046.md) | [8.8](/filings/0001174850-26-000077.md) | [9.0](/filings/0001174850-25-000023.md) | [8.9](/filings/0001174850-25-000036.md) | [9.0](/filings/0001174850-25-000062.md) | [9.2](/filings/0001174850-26-000164.md) | [15.6](/filings/0001174850-26-000110.md) | [15.4](/filings/0001174850-26-000164.md) |
| Total liabilities | $bn | [7.4](/filings/0001174850-23-000038.md) | [7.4](/filings/0001174850-25-000008.md) | [7.4](/filings/0001174850-24-000025.md) | [7.5](/filings/0001174850-24-000036.md) | [7.5](/filings/0001174850-24-000046.md) | [7.6](/filings/0001174850-26-000077.md) | [7.8](/filings/0001174850-25-000023.md) | [7.7](/filings/0001174850-25-000036.md) | [7.8](/filings/0001174850-25-000062.md) | [7.9](/filings/0001174850-26-000164.md) | [13.3](/filings/0001174850-26-000110.md) | [13.1](/filings/0001174850-26-000164.md) |
| Long-term debt | $bn | [0.2](/filings/0001174850-23-000038.md) | [0.2](/filings/0001174850-25-000008.md) | [0.2](/filings/0001174850-24-000025.md) | [0.2](/filings/0001174850-24-000036.md) | [0.2](/filings/0001174850-24-000046.md) | [0.2](/filings/0001174850-26-000077.md) | [0.2](/filings/0001174850-25-000023.md) | [0.1](/filings/0001174850-25-000036.md) | [0.1](/filings/0001174850-25-000062.md) | [0.1](/filings/0001174850-26-000164.md) | [0.2](/filings/0001174850-26-000110.md) | [0.1](/filings/0001174850-26-000164.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001174850-23-000038.md) | [0.0](/filings/0001174850-25-000008.md) | [0.0](/filings/0001174850-24-000025.md) | [0.0](/filings/0001174850-24-000036.md) | [0.0](/filings/0001174850-24-000046.md) | [0.0](/filings/0001174850-26-000077.md) | [0.0](/filings/0001174850-25-000023.md) | [0.0](/filings/0001174850-25-000036.md) | [0.0](/filings/0001174850-25-000062.md) | [0.0](/filings/0001174850-26-000164.md) | [0.0](/filings/0001174850-26-000110.md) | [0.0](/filings/0001174850-26-000164.md) |
| Shareholders' equity | $bn | [1.0](/filings/0001174850-24-000046.md) | [1.0](/filings/0001174850-26-000077.md) | [1.1](/filings/0001174850-25-000036.md) | [1.1](/filings/0001174850-25-000062.md) | [1.1](/filings/0001174850-25-000062.md) | [1.2](/filings/0001174850-26-000164.md) | [1.2](/filings/0001174850-26-000164.md) | [1.2](/filings/0001174850-26-000164.md) | [1.2](/filings/0001174850-25-000062.md) | [1.3](/filings/0001174850-26-000164.md) | [2.3](/filings/0001174850-26-000164.md) | [2.3](/filings/0001174850-26-000164.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.8 d](/filings/0001174850-24-000046.md) | [37.8 d](/filings/0001174850-26-000077.md) | [23.4](/filings/0001174850-25-000023.md) | [37.3 d](/filings/0001174850-25-000036.md) | [39.6 d](/filings/0001174850-25-000062.md) | [33.4 d](/filings/0001174850-26-000077.md) | [41.8](/filings/0001174850-26-000110.md) | [38.9 d](/filings/0001174850-26-000164.md) | [45.9 d](/filings/0001174850-25-000062.md) | [27.0 d](/filings/0001174850-26-000077.md) | [16.3](/filings/0001174850-26-000110.md) | [93.4 d](/filings/0001174850-26-000164.md) |
| Capital expenditure | $m | [2.5 d](/filings/0001174850-24-000046.md) | [3.5 d](/filings/0001174850-26-000077.md) | [3.3](/filings/0001174850-25-000023.md) | [2.9 d](/filings/0001174850-25-000036.md) | [4.9 d](/filings/0001174850-25-000062.md) | [5.7 d](/filings/0001174850-26-000077.md) | [0.5](/filings/0001174850-26-000110.md) | [0.5 d](/filings/0001174850-26-000164.md) | [(0.0) d](/filings/0001174850-25-000062.md) | [3.1 d](/filings/0001174850-26-000077.md) | [1.2](/filings/0001174850-26-000110.md) | [4.1 d](/filings/0001174850-26-000164.md) |
| Dividends paid | $m | [3.7 d](/filings/0001174850-24-000046.md) | [3.7 d](/filings/0001174850-26-000077.md) | [3.8](/filings/0001174850-25-000023.md) | [4.2 d](/filings/0001174850-25-000036.md) | [4.2 d](/filings/0001174850-25-000062.md) | [4.3 d](/filings/0001174850-26-000077.md) | [4.3](/filings/0001174850-26-000110.md) | [4.9 d](/filings/0001174850-26-000164.md) | [4.7 d](/filings/0001174850-25-000062.md) | [4.8 d](/filings/0001174850-26-000077.md) | [6.9](/filings/0001174850-26-000110.md) | [7.7 d](/filings/0001174850-26-000164.md) |
| Share repurchases | $m | [0.0 d](/filings/0001174850-24-000046.md) | [0.0 d](/filings/0001174850-26-000077.md) | [0.0](/filings/0001174850-25-000023.md) | [0.0 d](/filings/0001174850-25-000036.md) | [0.0 d](/filings/0001174850-25-000062.md) | [10.1 d](/filings/0001174850-26-000077.md) | [26.0](/filings/0001174850-26-000110.md) | [30.0 d](/filings/0001174850-26-000164.md) | [20.5 d](/filings/0001174850-25-000062.md) | [0.0 d](/filings/0001174850-26-000077.md) | [22.4](/filings/0001174850-26-000110.md) | [40.2 d](/filings/0001174850-26-000164.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.3](/filings/0001174850-23-000038.md) | [14.7](/filings/0001174850-24-000025.md) | [15.0](/filings/0001174850-24-000036.md) | [15.1](/filings/0001174850-24-000046.md) | [15.2](/filings/0001174850-25-000023.md) | [15.3](/filings/0001174850-25-000036.md) | [15.5](/filings/0001174850-25-000062.md) | [15.6](/filings/0001174850-26-000110.md) | [15.4](/filings/0001174850-26-000164.md) | [15.3](/filings/0001174850-25-000062.md) | [18.7](/filings/0001174850-26-000110.md) | [21.7](/filings/0001174850-26-000164.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,957,513 at 2026-07-30, from the cover of the [10-Q filed 2026-07-31](/filings/0001174850-26-000164.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.